GSK, Vir say their antibody treatment reduces Covid deaths

LONDON: British pharmaceutical giant GlaxoSmithKline (GSK) and California’s Vir Biotechnology said on Tuesday that an antibody treatment developed by them helped reduce both coronavirus deaths and hospitalisations.

© New Straits Times Press (M) Bhd